Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | MARS1 | P56192 | 7/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | METAP2 | P50579 | 2/20 | 0.40 |
| ▸ | METAP1 | P53582 | 2/20 | 0.40 |
| ▸ | CTSC | P53634 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MME | P08473 | 1/20 | 0.38 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | BCL2 | P10415 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7781980 | 1.00 | ATM (0.43) | ATML3MBTL1MARS1TDP1METAP2 | |
| Hydrochloric Acid SCHEMBL28125798 | 0.98 | ATM (0.42) | ATML3MBTL1MARS1TDP1METAP2 | |
| SCHEMBL12229268 | 0.86 | LMNA (0.43) | MARS1 | |
| SCHEMBL12229225 | 0.86 | LMNA (0.43) | MARS1 | |
| SCHEMBL19283982 | 0.84 | LMNA (0.49) | L3MBTL1MARS1TDP1POLB | |
| SCHEMBL180586 | 0.83 | PTPN1 (0.48) | TDP1 | |
| SCHEMBL23129826 | 0.82 | MARS1 (0.47) | ATML3MBTL1MARS1TDP1 | |
| Arginine SCHEMBL19283975 | 0.82 | FNTA (0.41) | MARS1CTSC | |
| SCHEMBL15993776 | 0.81 | TDP1 (0.42) | ATML3MBTL1MARS1TDP1CTSC | |
| SCHEMBL1133955 | 0.80 | KMT2A (0.53) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117320685-A | Composition for skin protection comprising an antimicrobial agent and a (bio) -alkanediol | 西姆莱斯股份公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-116685300-A | Composition comprising one or more (bio) -alkanediols with an antioxidant | 西姆莱斯股份公司 | 2023-09-01 | — | — | CN | disclosed |
| EP-3419595-A1 | STABLE LIQUID GONADOTROPIN FORMULATION | Ferring B.V. (NL) | 2019-01-02 | — | — | EP | disclosed |
| WO-2017144659-A1 | STABLE LIQUID GONADOTROPIN FORMULATION | FERRING B.V. (NL) | 2017-08-31 | — | — | WO | disclosed |
| CN-103931605-B | For the system and method for ex-vivo organ care | TRANSMEDICS INC. (US) | 2015-11-18 | — | — | CN | disclosed |
| CN-103931605-A | Systems and methods for ex-vivo organ care | TRANSMEDICS INC | 2014-07-23 | — | — | CN | disclosed |
| EP-2720712-A2 | STABLE FORMULATIONS OF A HYALURONAN-DEGRADING ENZYME | Halozyme, Inc. (US) | 2014-04-23 | — | — | EP | disclosed |
| CN-101072500-B | System and method for ex vivo organ care | TRANSMEDICS INC | 2013-12-04 | — | — | CN | disclosed |
| WO-2012174478-A9 | STABLE FORMULATIONS OF A HYALURONAN-DEGRADING ENZYME | HALOZYME, INC. (US) | 2013-05-30 | — | — | WO | disclosed |
| WO-2012174478-A2 | STABLE FORMULATIONS OF A HYALURONAN-DEGRADING ENZYME | HALOZYME, INC. (US) | 2012-12-20 | — | — | WO | disclosed |
| CN-101072500-A | System and method for ex vivo organ care | TRANSMEDICS INC (US) | 2007-11-14 | — | — | CN | disclosed |
| WO-2002040631-A2 | DIPEPTIDE SERYL-HISTIDINE AND RELATED OLIGOPEPTIDES CLEAVE DNA, PROTEIN, AND A CARBOXYL ESTER | OHIO UNIVERSITY (US) | 2002-05-23 | — | — | WO | disclosed |
| EP-1135398-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | Monsanto Technology LLC (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6218563-B1 | Cyanophosphonamides and method for preparation | MONSANTO COMPANY | 2001-04-17 | — | — | US | disclosed |
| WO-2000032611-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | MONSANTO TECHNOLOGY LLC (US) | 2000-06-08 | — | — | WO | disclosed |
| US-4304715-A | Enkephalin analogues | HUDSON DEREK | 1981-12-08 | — | — | US | disclosed |
| US-RE30731-E | Enkephalin analogues | Hudson, Derek (GB) | 1981-09-01 | — | — | US | disclosed |
| US-4198398-A | Enkephalin analogues | HUDSON DEREK (GB) | 1980-04-15 | — | — | US | disclosed |